ArticleMolecular medicine (Cambridge, Mass.)2025

An eCIRP inhibitor attenuates fibrosis and ferroptosis in ischemia and reperfusion induced chronic kidney disease.

Fangming Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.